(Q37951791)

25 August 2017

title

Lymphadenectomy in urologic oncology: pathologic considerations (English)

1 reference

25 August 2017

1 reference

Riley E Alexander

1

1 reference

25 August 2017

Ming-Tse Sung

series ordinal

2

1 reference

25 August 2017

Liang Cheng

series ordinal

3

1 reference

25 August 2017

publication date

21 September 2011

1 reference

Urologic Clinics of North America

25 August 2017

published in

1 reference

25 August 2017

volume

38

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

483-95, vii

1 reference

Laparoscopic extended pelvic lymph node dissection for prostate cancer: description of the surgical technique and initial results

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Handling and pathology reporting of renal tumor specimens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Handling and reporting of biopsy and surgical specimens of testicular cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Handling and pathology reporting of circumcision and penectomy specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Handling and pathology reporting of prostate biopsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Pelvic lymphadenectomy during radical cystectomy: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Guideline for optimization of surgical and pathological quality performance for radical prostatectomy in prostate cancer management: evidentiary base

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Handling and pathology reporting of radical prostatectomy specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Lymph node dissection in the management of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Lymph node dissection is not obsolete in clinically node-negative Renal Cell Carcinoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

The prognostic relevance of interactions between venous invasion, lymph node involvement and distant metastases in renal cell carcinoma after radical nephrectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

What does the urologist expect from the pathologist (and what can the pathologists give) in reporting on adult kidney tumour specimens?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Value of frozen section analysis of enlarged lymph nodes during radical nephrectomy for renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Staging and reporting of urothelial carcinoma of the urinary bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Does the greater number of lymph nodes removed during standard lymph node dissection predict better patient survival following radical cystectomy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Lymphadenectomy with cystectomy: is it necessary and what is its extent?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Comparison of 2002 TNM nodal status with lymph node density in node-positive patients after radical cystectomy for bladder cancer: analysis by the number of lymph nodes removed.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Intraoperative frozen section diagnosis in urological oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Lymph node assessment and lymphadenectomy in prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Pelvic lymph node dissection in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Controversies surrounding lymph node dissection for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Two Positive Nodes Represent a Significant Cut-off Value for Cancer Specific Survival in Patients with Node Positive Prostate Cancer. A New Proposal Based on a Two-Institution Experience on 703 Consecutive N+ Patients Treated with Radical Prostatecto

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Risk of prostate carcinoma death in patients with lymph node metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Histopathological characteristics of lymph node metastases predict cancer-specific survival in node-positive prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Extranodal extension in lymph node-positive prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Cancer volume of lymph node metastasis predicts progression in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Multifocal prostate cancer: biologic, prognostic, and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Dedifferentiation in the metastatic progression of prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

The influence of serial sections, immunohistochemistry, and extension of pelvic lymph node dissection on the lymph node status in clinically localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Significance of micrometastases in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

The role of the histopathologist in the management of testicular germ cell tumour in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Reliability and safety of current dynamic sentinel node biopsy for penile carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Diagnosis and staging of penile cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Non-invasive and minimally invasive staging of regional lymph nodes in penile cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Management of the lymph nodes in penile cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

EAU penile cancer guidelines 2009.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Sentinel lymph-node biopsy in patients with squamous cell carcinoma of the penis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Does microinvasion of the capsule and/or micrometastases in regional lymph nodes influence disease-free survival after radical prostatectomy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Molecular staging of prostatic cancer with RT-PCR assay for prostate-specific antigen in peripheral blood and lymph nodes: comparison with standard histological staging and immunohistochemical assessment of occult regional lymph node metastases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Molecular lymph node staging in bladder urothelial carcinoma: impact on survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Circulating tumor cells predict survival in patients with metastatic prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Circulating endothelial cells and progenitors: potential biomarkers of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

Lymph-node revealing solution: a new method for detecting minute lymph nodes in cystectomy specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.07.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UCL.2011.07.001

1 reference

25 August 2017

1 reference